CKD Bio Corp. (063160.KS) KSC

16,180.00

-80(-0.49%)

Updated at June 02 03:30PM

Currency In KRW

Valuation

Market Cap111.7B
Enterprise Value255.23B
P/E Ratio-15.26
PEG Ratio0.15
Price/Sales Ratio0.56
Price/Book Ratio0.71
Enterprise/Revenue1.49
Enterprise/EBITDA22.93

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.04
Operating Margin-0

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.05

Income Statement

Revenue160.07B
Revenue/Share28,845.16
Gross Profit26.1B
EBITDA19.26B
Net Income-2.89B
Diluted EPS-526.16

Balance Sheet

Total Cash1.03B
Total Cash/Share187.01
Total Debt147.68B
Total Debt/Equity1.18
Current Ratio1.1
Book Value Per Share22,784.84

Price History

52-Week Change-29.04
52-Week High27,650
52-Week Low15,890
Moving Average 50 Days18,842.2
Moving Average 200 Days20,859.95

Statistics

Average Volume23,155
Shares Outstanding5.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.09
Last Split Factor21:20
Last Split DateDecember 27, 2019